Propafenone Hydrochloride

CHEMBL1201063 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
377.9 g/mol
LogP
Phase
4

A hydrochloride salt form of propafenone with the same therapeutic properties. Used to treat certain serious abnormal heart rhythms, including atrial fibrillation and other supraventricular arrhythmias, by slowing electrical conduction in the heart to restore and maintain a normal rhythm.

Peso Molecular

377,9000 g/mol

TPSA

58,60 Ų

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1.Cl

InChI

InChI=1S/C21H27NO3.ClH/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17;/h3-11,18,22-23H,2,12-16H2,1H3;1H

Molecular Formula

C21H28ClNO3

HBD / HBA

3 / 4

Ligações Rotacionáveis

11

Átomos Pesados

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A hydrochloride salt form of propafenone with the same therapeutic properties. Used to treat certain serious abnormal heart rhythms, including atrial fibrillation and other supraventricular arrhythmias, by slowing electrical conduction in the heart to restore and maintain a normal rhythm.

Yes, Propafenone Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201063. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 36708. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.